𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen

✍ Scribed by Marleen Kok; Sabine C. Linn; Ryan K. Van Laar; Maurice P. H. M. Jansen; Teun M. van den Berg; Leonie J. M. J. Delahaye; Annuska M. Glas; Johannes L. Peterse; Michael Hauptmann; John A. Foekens; Jan G. M. Klijn; Lodewyk F. A. Wessels; Laura J. Van’t Veer; Els M. J. J. Berns

Publisher
Springer US
Year
2008
Tongue
English
Weight
348 KB
Volume
113
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Central nervous system progression of me
Central nervous system progression of metastatic breast cancer in patients treated with paclitaxel
✍ Ronnie J. Freilich; Andrew D. Seidman; Dr. Lisa M. Deangelis 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 474 KB 👁 2 views

Background. The possibility of tumor sanctuary sites in the central nervous system (CNS) of patients receiving paclitaxel has been suggested by laboratory data identifying low concentrations of drug in the brain and cerebrospinal fluid (CSF) of rats. Methods. The pattern of disease progression in p

Outcomes in patients with primary breast
Outcomes in patients with primary breast cancer and a subsequent diagnosis of endometrial cancer : Comparison of cohorts treated with and without tamoxifen
✍ Mandana Saadat; Pauline T. Truong; Hosam A. Kader; Caroline H. Speers; Eric Bert 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

## Abstract ## BACKGROUND. The study compared tumor characteristics and survival in women with breast cancer who subsequently developed endometrial cancer with or without a history of tamoxifen use. ## METHODS. The British Columbia Cancer Agency registry identified 163 women diagnosed with breas